Healthcare

KANEKA UBIQUINOL™ WINS NUTRAINGREDIENTS ASIA INGREDIENT OF THE YEAR: HEALTHSPAN AWARD 2026

BANGKOK, Sept. 4, 2026, 19:00 GMT-04

KANEKA-Healthspan-Awa

Read full article →

InnovHeart Announces First U.S. Saturn Transseptal TMVR System Implant, Reaching 15 Patients Globally

NEWTON, Mass. and MILAN, Sept. 3, 2026, 11:25 GMT-04

InnovHeart-TMVR-systm

Read full article →

Osteosarcoma Market is Set to Rise by 2036 as 8 Emerging Therapies Set to Drive Future Growth | DelveInsight

LAS VEGAS, Sept. 3, 2026, 10:31 GMT-04

DELVEINSIGHT

Read full article →

Radiation Dose Management Market worth $0.96 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 3, 2026, 10:30 GMT-04

MARKETSANDMARKETS

Read full article →

TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations

BOSTON, Sept. 3, 2026, 10:00 GMT-04

TraceLink

Read full article →

Resonant Clinical Solutions Expands Advanced-Therapy and Cryogenic Storage Capabilities with Acquisition of Creapharm Bioservices

LEESBURG, Va., Sept. 3, 2026, 09:29 GMT-04

Resonant-Expand-Cryo

Read full article →

ZEISS elevates ophthalmic workflows at ESCRS with new surgical and digital advancements

JENA, Germany, Sept. 3, 2026, 09:00 GMT-04

CarlZeissMeditecAG

Read full article →

Pulnovo Medical Announces Results of the PADN-HF-PH Trial at ESC Congress 2026, Simultaneously Published in The New England Journal of Medicine (NEJM)

SHANGHAI, Sept. 3, 2026, 08:09 GMT-04

Pulnovo

Read full article →

United Imaging secures CE mark for world's first dual wide-coverage CT family

ROTTERDAM, Netherlands, Sept. 3, 2026, 06:50 GMT-04

United-Imaging-Health

Read full article →

Gan & Lee and Menarini Group Partner to Advance Bofanglutide in Europe

BEIJING and FLORENCE, Italy, Sept. 3, 2026, 05:43 GMT-04

Menarini-Grp-Gan-Lee

Read full article →

ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT AUGUST 2026

GOTHENBURG, Sweden, Sept. 3, 2026, 04:23 GMT-04

ZINZINO-PrSalesReport

Read full article →

Lundbeck to highlight mechanistic insights on bexicaserin's dual mode of action at the European Epilepsy Congress

VALBY, Denmark, Sept. 3, 2026, 03:38 GMT-04

H-LUNDBECK-AS-EEC

Read full article →

SCIBASE RESOLVES ON A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 58 MILLION

STOCKHOLM, Sept. 3, 2026, 03:23 GMT-04

SCIBASE-rights-issue

Read full article →

7 Wolves Consulting Announces Release of Founder Danielle D. Pollard's Debut Book, Act Like a Lady, Speak Like a Wolf

OAK PARK, Ill., Sept. 2, 2026, 18:57 GMT-04

7-Wolves-Consulting

Read full article →

Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences

DUBLIN, Sept. 2, 2026, 16:33 GMT-04

Jazz-Pharmaceuticals

Read full article →

EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction

PROVIDENCE, R.I., Sept. 2, 2026, 11:16 GMT-04

EpiVax-AI-ISPRI

Read full article →

Autoimmune Uveitis Market to Expand at a CAGR of 7% During the Forecast Period (2026-2036) as Novel Treatments Challenge the Existing Therapeutic Landscape | DelveInsight

LAS VEGAS, Sept. 2, 2026, 10:31 GMT-04

DELVEINSIGHT-RESEARCH

Read full article →

Biosimilars Market worth $70.79 billion by 2036 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 2, 2026, 10:30 GMT-04

MARKETSANDMARKETS

Read full article →

ACTO Achieves Veeva Gold Product Partner Status, Following a Nearly Decade-Long Collaboration Supporting Mutual Customer Success

TORONTO and NEW YORK, Sept. 2, 2026, 08:30 GMT-04

ACTO-Technologies-

Read full article →

NovaGo Therapeutics Closes USD 30 Million Series B Financing to Advance Proof-of-Concept Study in Acute Spinal Cord Injury

SCHLIEREN, Switzerland, Sept. 2, 2026, 06:00 GMT-04

NovaGo-Therapeutics

Read full article →